Liang Lin

Liang Lin's work experience begins in 2016 at the Dana-Farber Cancer Institute, where they worked as a Research Fellow from August 2016 to July 2021.

In 2021, Liang Lin joined Cytovia Therapeutics as a Senior Scientist. They initially held the position of Senior Scientist from July 2021 to July 2022. Liang then progressed to the role of Senior Scientist II from August 2022 to February 2023. Currently, Liang holds the position of Senior Scientist III from March 2023 onwards at Cytovia Therapeutics.

Liang Lin completed a Doctor of Philosophy (PhD) degree in Immunology from Peking University from the years 2008 to 2016.